Oncotelic Therapeutics (OTLC) Stock Chart & Stock Price History $0.04 -0.01 (-26.32%) As of 09:30 AM Eastern Add Compare Share Share Chart Stock AnalysisChartHeadlinesSEC FilingsShort InterestBuy This Stock Oncotelic Therapeutics Stock Price Performance The Oncotelic Therapeutics (OTLC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 40.00%, with a year-to-date return of 0.00%. In the past month, the stock has decreased 32.69%, reflecting recent market activity. As of the latest close, Oncotelic Therapeutics traded at $0.05 with a market cap of $19.39 million and volume of 2,500 shares. Receive OTLC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oncotelic Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-31.77%1 Month Performance-32.69%3 Month Performance-40.58%Year-To-Date Performance0.00%1 Year Performance+40.00% OTLC Stock Chart for Friday, August, 8, 2025 OTLC Chart by TradingView Oncotelic Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/07/2025$0.05$0.05+3.04%$0.05$0.052,500 shs$19.39 million08/06/2025$0.05$0.05-9.43%$0.05$0.0466,499 shs$18.82 million08/05/2025$0.05$0.05+7.84%$0.05$0.0454,922 shs$20.78 million08/04/2025$0.05$0.05-7.99%$0.05$0.04336,839 shs$19.27 million08/01/2025$0.05$0.05-0.58%$0.05$0.0562,603 shs$20.95 million07/31/2025$0.05$0.05+2.18%$0.06$0.05368,872 shs$21.07 million07/30/2025$0.05$0.05$0.06$0.0576,050 shs$20.62 million07/29/2025$0.05$0.05-0.59%$0.06$0.0576,050 shs$20.62 million07/28/2025$0.05$0.05-0.39%$0.05$0.0516,529 shs$20.74 million07/25/2025$0.05$0.05+0.39%$0.06$0.05108,459 shs$20.82 million Get the Latest News and Ratings for OTLC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oncotelic Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/24/2025$0.05$0.05-0.39%$0.05$0.0547,897 shs$20.74 million07/23/2025$0.05$0.05+0.99%$0.05$0.0545,203 shs$20.82 million07/22/2025$0.05$0.05+0.80%$0.05$0.05114,384 shs$20.62 million07/21/2025$0.05$0.05-1.18%$0.05$0.05109,011 shs$20.46 million07/18/2025$0.05$0.05-0.78%$0.05$0.0563,727 shs$20.70 million07/17/2025$0.05$0.05+6.46%$0.06$0.05258,619 shs$20.86 million07/16/2025$0.06$0.05-17.24%$0.05$0.05154,016 shs$19.60 million07/15/2025$0.06$0.06$0.06$0.0411,118 shs$23.68 million07/14/2025$0.05$0.06+6.42%$0.06$0.0411,118 shs$23.68 million07/11/2025$0.05$0.05+6.86%$0.06$0.04815,380 shs$22.25 million07/10/2025$0.05$0.05-1.92%$0.05$0.05230,462 shs$20.82 million07/09/2025$0.05$0.05$0.05$0.0539,643 shs$21.23 million07/08/2025$0.05$0.05+5.05%$0.05$0.05275,653 shs$21.23 million07/07/2025$0.05$0.05+8.32%$0.05$0.04144,752 shs$20.21 million Related Companies ARMP Stock Price Chart XBIT Stock Price Chart ORMP Stock Price Chart ENTX Stock Price Chart MGX Stock Price Chart VTGN Stock Price Chart SRZN Stock Price Chart AVTX Stock Price Chart ABOS Stock Price Chart EXOZ Stock Price Chart Receive OTLC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oncotelic Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:OTLC) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncotelic Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncotelic Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
